1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Pharmaceutical Excipients Market Insights
4.1. Industry Value Chain Analysis
4.2. GROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. The threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Global Pharmaceutical Excipients Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.1.1. Inorganic Chemicals
5.2.1.1.1. Calcium Phosphates
5.2.1.1.2. Calcium Carbonate
5.2.1.1.3. Calcium Sulfate
5.2.1.1.4. Halites
5.2.1.1.5. Metallic Oxides
5.2.1.1.6. Others
5.2.1.2. Organic Chemical
5.2.1.2.1. Carbohydrates
5.2.1.2.1.1. Sugars
5.2.1.2.1.2. Starch
5.2.1.2.1.3. Cellulose
5.2.1.2.2. Petrochemicals
5.2.1.2.2.1. Glycols (Alcohol)
5.2.1.2.2.2. Povidones Polymers
5.2.1.2.2.3. Mineral Hydrocarbons
5.2.1.2.2.4. Others
5.2.2. By Function
5.2.2.1. Fillers & Diluents
5.2.2.2. Suspension & viscosity agents
5.2.2.3. Binders
5.2.2.4. Coatings
5.2.2.5. Flavoring agents
5.2.2.6. Disintegrants
5.2.2.7. Others
5.2.3. By Formulation
5.2.3.1. Oral Formulations
5.2.3.2. Parenteral Formulations
5.2.3.3. Topical Formulations
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. The Asia-Pacific
5.2.4.4. Latin America
5.2.4.5. The Middle East and Africa
6. North America Pharmaceutical Excipients Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Function
6.2.3. By Formulation
6.2.4. By Country
6.2.4.1. United States
6.2.4.2. Canada
7. Europe Pharmaceutical Excipients Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Function
7.2.3. By Formulation
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. United Kingdom
7.2.4.3. Italy
7.2.4.4. France
7.2.4.5. Spain
7.2.4.6. Rest of Europe
8. The Asia Pacific Pharmaceutical Excipients Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Function
8.2.3. By Formulation
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. South Korea
8.2.4.5. Rest of Asia Pacific
9. Latin America Pharmaceutical Excipients Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Function
9.2.3. By Formulation
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Mexico
9.2.4.3. Rest of Latin America
10. The Middle East & Africa Pharmaceutical Excipients Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Function
10.2.3. By Formulation
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of the Middle East & Africa
11. Competitive Landscape
11.1.
List of Key Players and Their Offerings
11.2. Market Share Analysis, 2021
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Development (Merger, Acquisition, Partnership.)
12. Impact of COVID-19 on Global Pharmaceutical Excipients Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
13.1. Ashland, Inc.
13.2. BASF SE
13.3. Associated British Foods Plc
13.4. Akzo Nobel N.V.
13.5. Roquette Frres
13.6. DuPont de Nemours
13.7. Innophos Holdings, Inc.
13.8. Evonik
13.9. Merck
13.10. The Lubrizol Corporation
13.11. Armor Pharma
13.12. J.M. Huber Corporation
13.13. Dow Chemicals Corporation
13.14. Merck Millipore
13.15. Daicel Corporation
13.16. Kerry
13.17. Croda International
13.18. Archer Daniels Midland
13.19. Other Prominent Players
14. Key Strategic Recommendations